Effect of Vitamin D on the Clinical and Radiographic of Unsplinted Mandibular Implant Overdentures

NCT ID: NCT07200011

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2025-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the effect of vitamin D on bone loss around mandibular implant overdentures. Bone levels around implants will be measured to understand how vitamin Daffect the health of implant-supported dentures. This information may help improve dental treatment outcomes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tooth loss affects patient's quality of life. The use of mandibular implant overdentures is an accepted treatment option that improves prosthesis retention, stability, and masticatory efficiency compared to conventional complete dentures.

Vitamin D plays a critical role in bone metabolism and osseointegration of dental implants. Deficiency may impair bone healing and accelerate peri-implant bone loss.

The purpose of this retrospective study is to clinically and radiographically evaluate the effect of serum vitamin D levels on peri-implant tissues in patients rehabilitated with unsplinted mandibular implant overdentures.

Patient records are screened for serum vitamin D levels, radiographs at baseline of loading and follow-up intervals ( 6 \& 12 months after loading )and clinical notes.

Patients categorize into two groups based on their recorded serum vitamin D levels: group A - deficient vitamin D : \< 20 ng/mL and group B - sufficient vitamin D: ≥ 30 ng/mL.

All participants rehabilitated with unsplinted, three-implant mandibular overdentures assisted by LOCATOR attachments. Minor variations in implant dimensions and positioning are accepted, provided the implants were placed in the midline and posterior regions.

All implants should be placed using a flapless surgical protocol with delayed loading protocol.

The clinical evaluation included peri-implant soft tissue parameters in patients records such as plaque index, gingival index, bleeding on probing, and probing pocket depth to monitor peri-implant health. Also, prosthesis-related factors, including stability, retention, and occlusion, were also evaluated and recorded. In addition, implant status were evaluated and recorded through mobility testing and the presence of peri-implant infection or suppuration .

Marginal bone loss (vertically and horizontally) is measured on the mesial and distal sides of each dental implant on the periapical radiographs by using the software program (Scanora light version 3.2.6; SOREDEX) calibration.

Vertical bone height (AB) is considered as the distance between the implant shoulder and the bone-to-implant contact parallel to the implant long axis. Radiographic vertical bone loss (VBL) is estimated by subtracting radiographic AB at T6 and T12 from AB at T0.

Actual VBL is calculated by multiplying the actual implant length by the radiographic VBL and dividing the result by the radiographic length of the implant to account for magnification error.

To measure the horizontal alveolar bone loss (HBL), the distance between the peri- implant bone level (C point of crest) \[which is the crossing Point of the tangent to the horizontal bone crest (CD line) and the tangent to the crater-shaped defect (CB line)\] and the implant at the (E Point) right angle is measured and referred to the horizontal bone level. To measure horizontal bone loss (HBL), the horizontal bone level at T6 and T12 is subtracted from T0.

Actual HBL is calculated by multiplying the actual implant diameter by the radiographic HBL and dividing the result by the radiographic diameter of the implant in order to account for magnification error.

Data are analyzed using statistical software (SPSS, version 22.0; SPSS Inc., Chicago, IL). The Shapiro-Wilk test is used to assess the normality of the bone loss data. Descriptive statistics are expressed as mean ± standard deviation. Repeated measures analysis of variance (ANOVA) is used to evaluate changes in bone loss over time, followed by the Tukey Post hoc test for pairwise comparisons between time intervals. Intergroup differences are assessed using the independent samples t test. A P value \<.05 is considered statistically significant at a 95% confidence level.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin D Deficiency Implant Assesment Radiography Clinical and Radiographic Effect

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Vitamin D, marginal bone loss, mandibular implant overdenture, un-splinted implants, LOCATOR attachments,periapical radiographs.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vitamin D-deficient (<20 ng/mL)

Participants with serum vitamin D \<20 ng/mL

Observational: Serum Vitamin D Levels

Intervention Type OTHER

Participants' serum vitamin D levels will be measured from existing laboratory records, and radiographic images of mandibular implant overdentures will be analyzed to assess marginal bone loss. No active treatment or experimental intervention will be administered

Vitamin D-sufficient (≥30 ng/mL)

Participants with serum vitamin D ≥30 ng/mL

Observational: Serum Vitamin D Levels

Intervention Type OTHER

Participants' serum vitamin D levels will be measured from existing laboratory records, and radiographic images of mandibular implant overdentures will be analyzed to assess marginal bone loss. No active treatment or experimental intervention will be administered

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational: Serum Vitamin D Levels

Participants' serum vitamin D levels will be measured from existing laboratory records, and radiographic images of mandibular implant overdentures will be analyzed to assess marginal bone loss. No active treatment or experimental intervention will be administered

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 40 and 60 years.
* Patients rehabilitated with unsplinted three-implant mandibular overdentures retained by LOCATOR attachments .
* Availability of recent serum vitamin D records at determined time intervals.
* Good general health without uncontrolled systemic diseases.

Exclusion Criteria

* Missing or incomplete patient records.
* Patients on medications known to affect bone metabolism.
* History of smoking or alcohol abuse.
* Patients with borderline serum vitamin D values (21-29 ng/mL) to avoid classification bias.
* Presence of active oral infections or untreated periodontal disease.
* Previous implant failure in the mandible.
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rahma elhussany mohammed

Lecturer, Department of Prosthodontics, Mansoura faculty of Dentistry, Egypt

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry, Mansoura University

Al Mansurah, Dakahlia Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://pubmed.ncbi.nlm.nih.gov/15507918/

Direct procedure for connecting a mandibular implant-retained overdenture with ball attachments

https://pubmed.ncbi.nlm.nih.gov/30681193/

A within-subject clinical trial on the conversion of mandibular two-implant to three-implant overdenture: Patient-centered outcomes and willingness to pay

https://pubmed.ncbi.nlm.nih.gov/27141169/

Comparison of masticatory efficiency, patient satisfaction for single, two, and three implants supported overdenture in the same patient: A pilot study

https://pubmed.ncbi.nlm.nih.gov/21909496/

Clinical and radiographic evaluation of three-implant-retained mandibular overdentures: a 3-year retrospective study

https://pubmed.ncbi.nlm.nih.gov/21664413/

Vitamin D and intestinal calcium absorption

https://pubmed.ncbi.nlm.nih.gov/27738389/

Is Low Serum Vitamin D Associated with Early Dental Implant Failure? A Retrospective Evaluation on 1625 Implants Placed in 822 Patients

https://pubmed.ncbi.nlm.nih.gov/37622616/

Correlation of Serum Vitamin D with Crestal Bone Level in Dental Implant Patients Using CBCT: A Clinical Retrospective Study

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R.25.07.10

Identifier Type: -

Identifier Source: org_study_id